About this trial
This pilot clinical trial aims to evaluate the effectiveness of manual lymphatic drainage (MLD) in reducing symptoms associated with primary dysmenorrhea in young women. Primary dysmenorrhea is a common gynecological condition characterized by intense pelvic pain during menstruation, often accompanied by fatigue, headache, and sleep disturbances. Despite its high prevalence, it is frequently underestimated, negatively impacting quality of life and daily activities.
The intervention consists of three monthly sessions of MLD performed during the late luteal phase, prior to menstruation. Outcome measures include pain intensity, abdominal circumference, pressure pain threshold, sleep quality, and health-related quality of life.
Eligibility criteria
Qualifiers
Female participants aged 18-25 years
Confirmed diagnosis of primary dysmenorrhea
Regular menstrual cycles
Ability to provide informed consent
Disqualifiers
Secondary dysmenorrhea
Use of hormonal contraceptives
Presence of pelvic pathology (endometriosis, polycystic ovary syndrome, fibroids)
Irritable bowel syndrome
Trial design
Treatments tested in this trial
- Manual Lymphatic Drainage (MLD)